Read what the White House is reading about a possible war on Alzheimer’s.

Almost every voter supports changing Medicare rules to allow for doctors to prescribe treatments for Alzheimer’s that are approved by the Food and Drug Administration (FDA), according to a new poll obtained exclusively by the Washington Reporter.

The poll, which sources tell the Reporter has made its way to the top levels of the White House, found that 92 percent of voters support a national strategy to finally defeat Alzheimer’s.

That near-universal support, found in the poll from Tony Fabrizio and Bob Ward on behalf of Plymouth Union Public Research, spanned 28 of the most competitive House districts in America; the poll’s margin of error is 2.8 percent.

Virtually every voter supported changing Medicare rules to make it easier for doctors to prescribe FDA-approved treatments that could slow Alzheimer’s; critically, the poll also found that voters would give President Donald Trump and congressional Republicans the credit, too.

A whopping 87 percent of voters would credit Trump if he orders Medicare to cover Alzheimer’s detection tests, and Republicans who back a similar policy go from a three point deficit against a Democrat to a 19 point lead.

One of the main reasons for this support, the pollsters found, is that 80 percent of voters believe that early detection and prevention of Alzheimer’s saves both taxpayers and Medicare billions of dollars.

This issue also hits home for a near-majority of Americans. 38 percent of voters in the surveyed battleground House districts said they have family or friends who have been affected by Alzheimer’s.

Read the full poll here.